Meet us at LSI Europe in London 2025

26 August 2025

Chief Executive Officer Darren Spencer will represent the company at LSI Europe, taking place in London.

Venous Stent B.V., a Netherlands-based medtech company developing next-generation venous stent technology, today announced that Chief Executive Officer Darren Spencer will represent the company at LSI Europe, taking place in London.

LSI Europe is one of the leading global forums for medical technology innovation, bringing together entrepreneurs, investors, and clinical leaders to highlight emerging solutions in healthcare. Spencer will present Venous Stent’s novel iliac venous stent platform, designed to overcome anatomical challenges and provide improved treatment options for patients with venous outflow obstruction and related conditions.

“We are honoured to participate in LSI Europe and share our vision for advancing venous stenting,” said Darren Spencer, CEO of Venous Stent B.V “Our technology is purpose-built to address longstanding limitations in vascular interventions, and this conference provides a unique opportunity to engage with strategic partners, investors, and clinicians who share our mission to improve patient outcomes.”

Venous Stent B.V. continues to progress toward its first-in-human study and is focused on building strategic collaborations to accelerate clinical adoption and regulatory pathways.